MKI67 and glioblastoma: This intervention significantly suppressed YFSS‐induced GBM differentiation, as evidenced by a marked reduction of TUBB3 expression (Figure S5C), alongside an increase in Ki‐67‐positive cells (Figure S5D) and elevated expression of the proliferation‐associated CyclinD1 (Figure S5E,F).